The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 5,686,790 | 1,331,801 | SH | SOLE | 1,331,801 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 3,675,000 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 36,600,204 | 8,061,719 | SH | SOLE | 8,061,719 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 9,690,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 7,581,196 | 2,485,638 | SH | SOLE | 2,485,638 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 9,278,487 | 1,642,210 | SH | SOLE | 1,642,210 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 45,400,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 76,967,799 | 1,332,545 | SH | SOLE | 1,332,545 | 0 | 0 | ||
INVIVYD INC | COM | 00534A102 | 7,632,596 | 1,937,207 | SH | SOLE | 1,937,207 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 75,110,344 | 324,619 | SH | SOLE | 324,619 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 15,555,600 | 1,431,058 | SH | SOLE | 1,431,058 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 20,099,721 | 8,663,673 | SH | SOLE | 8,663,673 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 25,068,340 | 400,197 | SH | SOLE | 400,197 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 5,980,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 116,993,608 | 10,473,913 | SH | SOLE | 10,473,913 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 313,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 18,812,153 | 1,822,883 | SH | SOLE | 1,822,883 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 263,251,079 | 3,577,267 | SH | SOLE | 3,577,267 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 109,516,148 | 3,904,319 | SH | SOLE | 3,904,319 | 0 | 0 | ||
RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 6,241,574 | 8,434,560 | SH | SOLE | 8,434,560 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 66,893,930 | 14,232,751 | SH | SOLE | 14,232,751 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 19,220,791 | 3,130,422 | SH | SOLE | 3,130,422 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 21,421,004 | 2,749,808 | SH | SOLE | 2,749,808 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 28,637,364 | 2,892,663 | SH | SOLE | 2,892,663 | 0 | 0 | ||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 14,183,885 | 16,915,784 | SH | SOLE | 16,915,784 | 0 | 0 | ||
XILIO THERAPEUTICS INC | COM | 98422T100 | 1,542,977 | 2,805,413 | SH | SOLE | 2,805,413 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 31,903,517 | 1,112,396 | SH | SOLE | 1,112,396 | 0 | 0 |